1.A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncolog.
So Yeon JEON ; Hye Sook HAN ; Woo Kyun BAE ; Moo Rim PARK ; Hyeok SHIM ; Sang Cheol LEE ; Se Il GO ; Hwan Jung YUN ; Yong Jin IM ; Eun Kee SONG
Cancer Research and Treatment 2019;51(1):90-97
PURPOSE: Data on the efficacy of olanzapine in patients receiving moderately emetogenic chemotherapy (MEC) are limited. This study aimed to evaluate and compare the efficacy of olanzapine versus placebo in controlling nausea and vomiting in patients receiving MEC. MATERIALS AND METHODS: We conducted a randomized, double-blind, placebo-controlled study to determine whether olanzapine can reduce the frequency of chemotherapy-induced nausea and vomiting (CINV) and improve the quality of life (QOL) in patients receiving palonosetron and dexamethasone as prophylaxis for MEC-induced nausea and vomiting. The primary end point was complete response for the acute phase (0-24 hours after chemotherapy). The secondary end points were complete response for the delayed (24-120 hours) and overall phase (0-120 hours), proportion of significant nausea (visual analogue scale ≥ 25 mm), use ofrescue medications, and effect on QOL. RESULTS: Fifty-six patients were randomized to the olanzapine (n=29) and placebo (n=27) groups. Complete response rates were not significantly different between the olanzapine and placebo groups in the acute (96.5% vs. 88.0%, p=0.326), delayed (69.0% vs. 48.0%, p=0.118), and overall phases (69.0% vs. 48.0%, p=0.118). However, the percentage of patients with significant nausea (17.2% vs. 44.0%, p=0.032) and the use of rescue medications (0.03±0.19 vs. 1.88±2.88, p=0.002) were lower in the olanzapine group than in the placebo. Furthermore, the olanzapine group demonstrated better QOL (p=0.015). CONCLUSION: Olanzapine combined with palonosetron and dexamethasone significantly improved QOL and vomiting control among previously untreated patients receiving MEC, although the efficacy was limited to the reduction of the frequency of CINV.
Antiemetics
;
Dexamethasone
;
Drug Therapy*
;
Humans
;
Nausea*
;
Quality of Life
;
Vomiting*
2.A universal ultrasound diagnostic system developed to support urology and coloproctological applications
Jeong Seok KIM ; Jong Gun LEE ; Jae Hyeok CHOI ; Bong Hyo HAN ; Se Leang YOON ; Ho JUNG ; Tai Kyong SONG ; Jae Young LEE
Biomedical Engineering Letters 2019;9(1):119-125
In this study, we sought to describe a novel imaging apparatus that is lightweight, inexpensive, and highly eff ective for use in colorectal diagnostic and treatment settings. Typical probes for use in colorectal ultrasonic imaging applications are developed for surgeons to diagnose and stage rectal tumors and image the rectum and anus. Here we outline a new technique and use it for colorectal imaging in an animal. This technique involves use of an ultrasound array module positioned along the axis of rotation such that improved rotation is possible. This module is in the shape of a linear rod with a rotary linear component that allows for emission of focused ultrasonic echo signals from a linear section of the probe. The usability of the transducer and rectal image quality are satisfactory in a porcine model with the technique proposed here, axial/lateral resolution as 0.96/2.24 mm with 6 dB applied through the contour map using the point spread function. When compared to currently available methods, this technique provides superior diagnostic 3D volumetric image quality with reduced acquisition time. Given this, the ultrasound device proposed here may prove a viable and preferable method to those currently available for urology and colorectal imaging applications.
Anal Canal
;
Animals
;
Methods
;
Rectal Neoplasms
;
Rectum
;
Surgeons
;
Transducers
;
Ultrasonics
;
Ultrasonography
;
Urology
3.Long-Term Effects of Adenotonsillectomy on Growth and Symptoms in Childhood.
Woo Sung PARK ; Yong Bae JI ; Seung Hwan LEE ; Jin Hyeok JEONG ; Chang Myeon SONG ; Kyung TAE
Korean Journal of Otolaryngology - Head and Neck Surgery 2018;61(12):681-685
BACKGROUND AND OBJECTIVES: This study was performed to evaluate the long-term effect of adenotonsillectomy on childhood growth by examining preoperative growth status and presenting symptoms. SUBJECTS AND METHOD: One hundred and four patients who underwent adenotonsillectomy from January to December 2009 were enrolled in this study. Clinical data were collected from medical record reviews and through the administered questionnaire. We investigated symptoms and growth changes during 5 years following the surgery. RESULTS: The mean age of patients was 6.0±1.94 years (range, 3–10), with the male to female ratio of 62:42. Pre-operative symptoms were significantly improved after the surgery. The mean pre-operative height and weight percentiles were 53.6±27.4 and 59.6±29.2 at initial evaluation, and 67.1±26.4 and 59.6±28.6 at 5 years post adenotonsillectomy (p < 0.001, p=0.989), respectively. An increase in height percentile was more prominent in patients whose pre-operative height percentile was less than 50 compared to those with a percentile of 50 or more (p < 0.001). Weight percentile was significantly increased in those with the pre-operative weight percentile of less than 50 and decreased in patients with a percentile of 50 or more. CONCLUSION: Adenotonsillectomy has a positive effect on height growth in children with adenotonsillar hypertrophy, especially in patients whose height percentile is less than 50. Weight gain also can be expected in preoperative low-weight children.
Adenoidectomy
;
Child
;
Female
;
Humans
;
Hypertrophy
;
Male
;
Medical Records
;
Methods
;
Tonsillectomy
;
Weight Gain
4.2018 KHRS guideline for the evaluation and management of syncope: Part 2
Yoo Ri KIM ; Kwang Jin CHUN ; June Soo KIM ; Hee Sun MUN ; Junbeom PARK ; Dae Won SEO ; Mi Kyoung SONG ; Jinhee AHN ; Hee YOON ; Dae In LEE ; Young Soo LEE ; Myung jin CHA ; Eun Jung BAE ; Dae Hyeok KIM
International Journal of Arrhythmia 2018;19(2):145-185
The general concept and initial approach to syncope patients has been mentioned in the general sections. This special sections have been described the characteristics, diagnosis, and treatment with patient education for the each syncope. It has been described in order of reflex syncope, orthostatic hypotension, postural orthostatic tachycardia syndrome (POTS), cardiac syncope, and unexplained syncope. Several clinical issues will have been dealt with in special issues. Neurological assessment is added when the patients were diagnosed with psychogenic pseudosyncope (PPS). Although many childhood syncope caused by reflex syncope, they are also presented as syncope caused by arrhythmic events in patients with congenital heart disease. In the elderly patients, syncope is because of not only a single cause of syncope but a combination of various conditions. In case of a syncope patient visiting the emergency department, a standardized systematic approach will be required to determine whether hospitalize the patient according to the risk of recurrence and the needs for the syncope management unit. We also mention recommendations on the limits of driving, exercising and social life style that are relevant to syncope in all patients. In this guideline, we reviewed the Korean published literatures and European/American guidelines on syncope. We, writing and publishing committee for evaluation and management guidelines of syncope in the Korean Society for Holter and Noninvasive Electrocardiography (KSHNE) under the Korean Heart Rhythm Society (KHRS) are very pleased to be able to publish this guideline. We also hope this guideline will be a good support to manage the syncope patients and a useful trigger for further research in Korea.
Aged
;
Diagnosis
;
Electrocardiography
;
Emergency Service, Hospital
;
Heart
;
Heart Defects, Congenital
;
Hope
;
Humans
;
Hypotension, Orthostatic
;
Korea
;
Life Style
;
Patient Education as Topic
;
Postural Orthostatic Tachycardia Syndrome
;
Recurrence
;
Reflex
;
Syncope
;
Writing
5.2018 KHRS guideline for the evaluation and management of syncope: Part 1
Junbeom PARK ; Myung jin CHA ; Dae Hyeok KIM ; Yoo Ri KIM ; Hee Sun MUN ; Eun Jung BAE ; Dae Won SEO ; Mi Kyoung SONG ; Jinhee AHN ; Hee YOON ; Young Soo LEE ; Kwang Jin CHUN ; Dae In LEE ; June Soo KIM
International Journal of Arrhythmia 2018;19(2):126-144
Syncope is a very common symptom that occurs in all age groups, especially in adolescents and elderly people. The cause of syncope is very diverse, and patients with syncope visit various medical departments such as general medicine, cardiology, neurology, and emergency medicine. If we do not perform appropriate diagnostic tests based on detailed history of syncope, we may have some difficulty to identify the cause of syncope. Failure to identify the cause of syncope can lead to physical trauma due to recurrence of syncope or may increase the risk of cardiovascular events in the future. However, there is no Korean guidelines for the diagnosis and treatment of syncope yet. Considering these circumstances in Korea, we prepared writing and publishing committee for evaluation and management guidelines of syncope in the Korean Society for Holter and Noninvasive Electrocardiology (KSHNE) under the Korean Heart Rhythm Society (KHRS). In this guideline, we reviewed the Korean published literatures and European / American guidelines on syncope.
Adolescent
;
Aged
;
Cardiology
;
Diagnosis
;
Diagnostic Tests, Routine
;
Emergency Medicine
;
Heart
;
Humans
;
Korea
;
Neurology
;
Recurrence
;
Syncope
;
Writing
6.Is it possible to reduce intra-hospital transport time for computed tomography evaluation in critically ill cases using the Easy Tube Arrange Device?.
Kyung Hyeok SONG ; Sung Uk CHO ; Jin Woong LEE ; Yong Chul CHO ; Won Joon JEONG ; Yeon Ho YOU ; Seung RYU ; Seung Whan KIM ; In Sool YOO ; Ki Hyuk JOO
Clinical and Experimental Emergency Medicine 2018;5(1):14-21
OBJECTIVE: Patients are often transported within the hospital, especially in cases of critical illness for which computed tomography (CT) is performed. Since increased transport time increases the risks of complications, reducing transport time is important for patient safety. This study aimed to evaluate the ability of our newly invented device, the Easy Tube Arrange Device (ETAD), to reduce transport time for CT evaluation in cases of critical illness. METHODS: This prospective randomized control study included 60 volunteers. Each participant arranged five or six intravenous fluid lines, monitoring lines (noninvasive blood pressure, electrocardiography, central venous pressure, arterial catheter), and therapeutic equipment (O2 supply device, Foley catheter) on a Resusci Anne mannequin. We measured transport time for the CT evaluation by using conventional and ETAD method. RESULTS: The median transport time for CT evaluation was 488.50 seconds (95% confidence interval [CI], 462.75 to 514.75) and, 503.50 seconds (95% CI, 489.50 to 526.75) with 5 and 6 fluid lines using the conventional method and 364.50 seconds (95% CI, 335.00 to 388.75), and 363.50 seconds (95% CI, 331.75 to 377.75) with ETAD (all P < 0.001). The time differences were 131.50 (95% CI, 89.25 to 174.50) and 148.00 (95% CI, 116.00 to 177.75) (all P < 0.001). CONCLUSION: The transport time for CT evaluation was reduced using the ETAD, which would be expected to reduce the complications that may occur during transport in cases of critical illness.
Blood Pressure
;
Central Venous Pressure
;
Critical Illness*
;
Electrocardiography
;
Humans
;
Manikins
;
Methods
;
Patient Safety
;
Prospective Studies
;
Transportation
;
Volunteers
7.Analysis of Motion-dependent Clinical Outcome of Tumor Tracking Stereotactic Body Radiotherapy for Prostate Cancer.
Hoon Sik CHOI ; Ki Mun KANG ; Bae Kwon JEONG ; Jin Ho SONG ; Yun Hee LEE ; In Bong HA ; Sung Chul KAM ; Jeong Seok HWA ; Jae Seog HYUN ; Jungmo DO ; Dong Hyeok JEONG ; Hojin JEONG
Journal of Korean Medical Science 2018;33(14):e107-
BACKGROUND: To analyze clinical outcome of CyberKnife (CK) tumor-tracking stereotactic body radiotherapy (SBRT) for prostate cancer (Pca) according to the magnitude of intra-fractional prostate motion. METHODS: Medical records and daily treatment logs for 71 patients who received CK tumor-tracking SBRT were retrospectively analyzed. Statistical relationships between prostate motion and various outcome results, including local recurrence (LR), biochemical failure (BF), and treatment-related toxicity, were investigated in order to evaluate motion-dependent efficacy of tumor-tracking SBRT for Pca. RESULTS: In a total 71 patients, 3 (4.2%) patients with LR, 12 (16.9%) patients with BF, and 22 (31%) patients with grade-II or worse toxicities to rectal or bladder (22 to rectal, 22 to bladder and 8 patients to both) were observed in a median follow-up of 47 months. Magnitudes of intra-fractional tumor motion along superior-inferior, right-left, and anterior-posterior (AP) axes were 0.15 ± 0.31, 0.12 ± 0.19, and 0.73 ± 0.32 mm, respectively. Radial magnitude was estimated to be 1.0 ± 0.35 mm. Intra-fractional movement was not significantly correlated with tumor control. However, it was significant correlated with the incidence of grade-II or worse toxicity to rectum or bladder particularly when tumor motion was in the AP axis. CONCLUSION: Our quantitative results revealed that toxicity related to SBRT treatment was highly sensitive to intra-fractional prostate movements, although local-tumor control was not affected by such movements. Our results demonstrate that precise motion correction is essential in prostate SBRT, even if it seems to be small.
Follow-Up Studies
;
Humans
;
Incidence
;
Medical Records
;
Passive Cutaneous Anaphylaxis
;
Prostate*
;
Prostatic Neoplasms*
;
Radiosurgery*
;
Rectum
;
Recurrence
;
Retrospective Studies
;
Urinary Bladder
8.A Case of Periorbital Necrotizing Fasciitis Occurred in Patient with Fungal Sinusitis
Dong Hwan KIM ; Min Song KIM ; Han Seok YOO ; Jin Hyeok JEONG
Korean Journal of Otolaryngology - Head and Neck Surgery 2018;61(1):56-60
Orbital complications due to sinusitis usually occur in children and spread from the ethmoid or frontal sinusitis. Periorbital necrotizing fasciitis, which is an aggressive infection characterized by extensive necrosis and gas formation in the fascia and subcutaneous tissue, is uncommon as an orbital complication due to sinusitis. Because most of orbital complications of the fungal sinusitis occur from invasive fungal infection in immunocompromised patients, orbital complications due to non-invasive maxillary fungal ball in healthy patients are extremely rare, especially if the complication is periorbital necrotizing fasciitis. We report a case of periorbital necrotizing fasciitis that occurred in a healthy 44-year-old male patient with non-invasive fungal sinusitis, which was treated with a combination of intravenous antibiotics and endoscopic sinus surgery and ophthalmologic surgical treatment.
Adult
;
Anti-Bacterial Agents
;
Child
;
Fascia
;
Fasciitis, Necrotizing
;
Frontal Sinus
;
Frontal Sinusitis
;
Humans
;
Immunocompromised Host
;
Male
;
Necrosis
;
Orbit
;
Sinusitis
;
Subcutaneous Tissue
9.Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep
Young Hee SUNG ; Hee Jin KIM ; Seong Beom KOH ; Joong Seok KIM ; Sang Jin KIM ; Sang Myung CHEON ; Jin Whan CHO ; Yoon Joong KIM ; Hyeo Il MA ; Mee Young PARK ; Jong Sam BAIK ; Phil Hyu LEE ; Sun Ju CHUNG ; Jong Min KIM ; In Uk SONG ; Han Joon KIM ; Ji Young KIM ; Do Young KWON ; Jae Hyeok LEE ; Jee Young LEE ; Ji Seon KIM ; Ji Young YUN ; Jin Yong HONG ; Mi Jung KIM ; Jinyoung YOUN ; Ji Sun KIM ; Eung Seok OH ; Hui Jun YANG ; Won Tae YOON ; Sooyeoun YOU ; Kyum Yil KWON ; Hyung Eun PARK ; Su Yun LEE ; Younsoo KIM ; Hee Tae KIM ; Tae Beom AHN
Journal of Korean Medical Science 2018;33(2):e14-
BACKGROUND: Sleep problems commonly occur in patients with Parkinson's disease (PD), and are associated with a lower quality of life. The aim of the current study was to translate the English version of the Scales for Outcomes in Parkinson's Disease-Sleep (SCOPA-S) into the Korean version of SCOPA-S (K-SCOPA-S), and to evaluate its reliability and validity for use by Korean-speaking patients with PD. METHODS: In total, 136 patients with PD from 27 movement disorder centres of university-affiliated hospitals in Korea were enrolled in this study. They were assessed using SCOPA, Hoehn and Yahr Scale (HYS), Unified Parkinson's Disease Rating Scale (UPDRS), Parkinson's Disease Sleep Scale 2nd version (PDSS-2), Non-motor Symptoms Scale (NMSS), Montgomery Asberg Depression Scale (MADS), 39-item Parkinson's Disease Questionnaire (PDQ39), Neurogenic Orthostatic Hypotension Questionnaire (NOHQ), and Rapid Eye Movement Sleep Behaviour Disorder Questionnaire (RBDQ). The test-retest reliability was assessed over a time interval of 10–14 days. RESULTS: The internal consistency (Cronbach's α-coefficients) of K-SCOPA-S was 0.88 for nighttime sleep (NS) and 0.75 for daytime sleepiness (DS). Test-retest reliability was 0.88 and 0.85 for the NS and DS, respectively. There was a moderate correlation between the NS sub-score and PDSS-2 total score. The NS and DS sub-scores of K-SCOPA-S were correlated with motor scale such as HYS, and non-motor scales such as UPDRS I, UPDRS II, MADS, NMSS, PDQ39, and NOHQ while the DS sub-score was with RBDQ. CONCLUSION: The K-SCOPA-S exhibited good reliability and validity for the assessment of sleep problems in the Korean patients with PD.
Depression
;
Humans
;
Hypotension, Orthostatic
;
Korea
;
Movement Disorders
;
Parkinson Disease
;
Quality of Life
;
Reproducibility of Results
;
Sleep, REM
;
Weights and Measures
10.Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
Dongxu KANG ; Zhezhu HAN ; Geun Hyeok OH ; Yeonsoo JOO ; Hye Jin CHOI ; Jae J SONG
Yonsei Medical Journal 2017;58(5):899-909
PURPOSE: Sorafenib, a multikinase inhibitor, is the standard therapy for patients with advanced-stage hepatocellular carcinoma (HCC). However, resistance develops to the treatment, therefore, we tried to unravel the underlying mechanism in the resistance of HCC cells to sorafenib via the development of more effective therapeutic strategies. MATERIALS AND METHODS: Various liver cancer cell lines were treated with either sorafenib only or with sorafenib after infection of adenovirus expressing short hairpin RNA (shRNA) against transforming growth factor-β (TGF-β) and p38 activity was examined using western blotting. RESULTS: p38 MAP kinase activity was inhibited by low concentrations of sorafenib, which could potentially lead to sorafenib resistance in HCC cell lines. Subsequently, we used constitutive form of MKK3/6 (MKK3/6E) to confirm that massive cell death was induced by the activation of p38, and demonstrated the ability to activate p38 without any stimulation. In addition, sorafenib resistance was reduced by the activation of p38. Subsequently, we confirmed that TGF-β shRNA effectively recovered the phosphorylation of p38 inhibited by sorafenib, and increased the sensitivity of HCC cells to sorafenib, thereby inducing cell death and overcoming the resistance of HCC cells to sorafenib. CONCLUSION: Our study provides a new therapeutic strategy for HCC that overcomes the resistance of HCC to sorafenib by down-regulation of TGF-β.
Adenoviridae
;
Blotting, Western
;
Carcinoma, Hepatocellular*
;
Cell Death
;
Cell Line
;
Down-Regulation*
;
Humans
;
Liver Neoplasms
;
p38 Mitogen-Activated Protein Kinases
;
Phosphorylation
;
RNA, Small Interfering

Result Analysis
Print
Save
E-mail